Skip to main content

#160438

UM-UC-7 (Human transitional cell carcinoma of the bladder) cell line

Cat. #160438

UM-UC-7 (Human transitional cell carcinoma of the bladder) cell line

Cat. #: 160438

Unit size: 1x10^6 cells / vial

Organism: Human

Tissue: Bladder

Disease: Cancer

Model: Tumourigenic cell line

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: H. Grossman ; Anita Sabichi

Institute: University of Michigan

Tool Details
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: UM-UC-7 (Human transitional cell carcinoma of the bladder) cell line
  • Alternate name: UMUC7; University of Michigan-Urothelial Carcinoma-7
  • Cancer: Genitourinary cancer
  • Cancers detailed: Human bladder transitional cell carcinoma
  • Research fields: Cancer
  • Organism: Human
  • Tissue: Bladder
  • Disease: Cancer
  • Growth properties: Adherent
  • Model: Tumourigenic cell line
  • Description: UM-UC-7 is a human transitional cell carcinoma cell line derived from a male bladder cancer patient. The UM-UC panel of urothelial carcinoma is a diverse range of 11 patient derived cell lines developed by the university of Michigan that have been well-categorised in the literature. These cells were assessed for their susceptibility to adenoviral mediated gene delivery, tumour growth in nude mice and differences in genetic alterations.

Handling

  • Format: Frozen
  • Growth medium: Cells were grown in EMEM (EBSS) + 2mM Glutamine + 1% Non Essential Amino Acids (NEAA) + 10% Foetal Bovine Serum (FBS).
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice
  • Subculture routine: Split sub-confluent cultures (70-80%) 1:3 to 1:6 i.e. seeding at 2-4x10,000 cells/cm2; using 0.05% trypsin/EDTA; 5% CO2, 37°C. Doubling time approximately 19 hours.

Related Tools

  • Related tools: UM-UC-1 (Human bladder transitional cell carcinoma) cell line ; UM-UC-3 (Human bladder transitional cell carcinoma) cell line ; UM-UC-4 (Human adenocarcinoma lymph node metastasis) cell line ; UM-UC-5 (Human squamous cell carcinoma of the bladder) cell line ; UM-UC-9 (Human transitional cell carcinoma of the bladder) cell line ; UM-UC-10 (Human transitional cell carcinoma of the bladder) cell line

References

  • Grossman et al. 1986. J Urol. 136(5):953-9. PMID: 3761468
  • Park et al. 2008. J Natl Cancer Inst. 100(19):1401-11. PMID: 18812553
  • Guo et al. 2013. J Pathol. 230(1):17-27. PMID: 23401075
  • Allory et al. 2014. Eur Urol. 65(2):360-6. PMID: 24018021
  • Earl et al. 2015. BMC Genomics. 16:403. PMID: 25997541
  • Zuiverloon et al. 2018. Bladder Cancer. 4(2):169-83. PMID: 29732388

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.